Ross Kedl, PhD

Professor of Immunology & Microbiology
University of Colorado

Ross KedlDr. Kedl received his PhD in 1997 in the Department of Laboratory Medicine and Pathology at the University of Minnesota in Minneapolis. Before joining the Faculty at the University of Colorado, Dr. Kedl was at 3M Pharmaceuticals working in their small molecule immune response modifier program. In his three years there, he spearheaded efforts at developing novel vaccine adjuvants, resulting in numerous publications and patents in the area of vaccine technology. Dr. Kedl returned to the academic sector in 2004 by joining the faculty in the Integrated Department of Immunology at the University of Colorado Health Sciences Center and National Jewish Medical Research Center where he continues to pursue the discovery and development of novel and clinically applicable vaccine technology. He is also the founder of a start-up pharmaceutical company, ImmuRx Inc., which focuses on developing therapeutic vaccines against chronic infectious diseases, such as HIV and cancer.

Biography from University of Colorado.

IDIGH Calendar

<<  <  April 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    2  3  4  5
  6  7  9101112
1314161819
202122232526
272830   

Latest IDIGH Publications

  1. Maurer, M., Aberer, W., Agondi, R., Al-Ahmad, M., Al-Nesf, M. A., Ansotegui, I., Arnaout, R., Arruda, L. K., Asero, R., Aygören-Pürsün, E., Banerji, A., Bauer, A., Ben-Shoshan, M., Berardi, A., Bernstein, J. A., Betschel, S., Bindslev-Jensen, C., Bizjak, M., Boccon-Gibod, I., Bork, K., Bouillet, L., Boysen, H. B., Brodszki, N., Broesby-Olsen, S., Busse, P., Buttgereit, T., Bygum, A., Caballero, T., Campos, R. A., Cancian, M., Cherrez-Ojeda, I., Cohn, D. M., Costa, C., Craig, T., Criado, P. R., Criado, R. F., Csuka, D., Dissemond, J., Du-Thanh, A., Ensina, L. F., Ertaş, R., Fabiani, J. E., Fantini, C., Farkas, H., Ferrucci, S. M., Figueras-Nart, I., Fili, N. L., Fomina, D., Fukunaga, A., Gelincik, A., Giménez-Arnau, A., Godse, K., Gompels, M., Gonçalo, M., Gotua, M., Gower, R., Grumach, A. S., Guidos-Fogelbach, G., Hide, M., Ilina, N., Inomata, N., Jakob, T., Josviack, D. O., Kang, H.-R., Kaplan, A., Kasperska-Zając, A., Katelaris, C., Kessel, A., Kleinheinz, A., Kocatürk, E., Košnik, M., Krasowska, D., Kulthanan, K., Kumaran, M. S., Larco, J. I., Longhurst, H. J., Lumry, W., MacGinnitie, A., Magerl, M., Makris, M. P., Malbrán, A., Marsland, A., Martinez-Saguer, I., Medina, I. V., Meshkova, R., Metz, M., Nasr, I., Nicolay, J., Nishigori, C., Ohsawa, I., Özyurt, K., Papadopoulos, N. G., Parisi, C. A., Peter, J. G., Pfützner, W., Popov, T., Prior, N., Ramon, G. D., Reich, A., Reshef, A., Riedl, M. A., Ritchie, B., Röckmann-Helmbach, H., Rudenko, M., Salman, A., Sanchez-Borges, M., Schmid-Grendelmeier, P., Serpa, F. S., Serra-Baldrich, E., Sheikh, F. R., Smith, W., Soria, A., Staubach, P., Steiner, U. C., Stobiecki, M., Sussman, G., Tagka, A., Thomsen, S. F., Treudler, R., Valle, S., van Doorn, M., Varga, L., Vázquez, D. O., Wagner, N., Wang, L., Weber-Chrysochoou, C., Ye, Y.-M., Zalewska-Janowska, A., Zanichelli, A., Zhao, Z., Zhi, Y., Zuberbier, T., Zwiener, R. D. & Castaldo, A.
    (2020)
    .
    Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence
    .
    Allergy
  2. Dubé, J.-Y., McIntosh, F., Zarruk, J. G., David, S., Nigou, J. & Behr, M. A.
    (2020)
    .
    Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant
    .
    Scientific reports
    ,
    vol
    .
    10
    ,
    p
    .
    5874
    .
  3. Miles, B. T., Gabrielli, S., Clarke, A., Eisman, H., Shand, G. & Ben-Shoshan, M.
    (2020)
    .
    Rates of anaphylaxis for the most common food allergies
    .
    The journal of allergy and clinical immunology. In practice
  4. Park, J. H., Lee, K. H., Jeon, B., Ochs, H. D., Lee, J. S., Gee, H. Y., Seo, S., Geum, D., Piccirillo, C., Eisenhut, M., van der Vliet, H. J., Lee, J. M., Kronbichler, A., Ko, Y. & Shin, J. I.
    (2020)
    .
    Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review
    .
    Autoimmunity reviews
    ,
    p
    .
    102526
    .
  5. Weir, D. L., Lee, T. C., McDonald, E. G., Motulsky, A., Abrahamowicz, M., Morgan, S., Buckeridge, D. & Tamblyn, R.
    (2020)
    .
    Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events
    .
    Journal of the American Geriatrics Society
More publications